Quint Media Inc Stock Other OTC
Equities
US74874T1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | 0.57 | Sales 2023 | 0.61 | Capitalization | 5.54M |
---|---|---|---|---|---|
Net income 2022 | -12M | Net income 2023 | -30M | EV / Sales 2022 | 44,915,754 x |
Net Debt 2022 | 3.98M | Net Debt 2023 | 18.76M | EV / Sales 2023 | 40,045,900 x |
P/E ratio 2022 |
-1.59
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.39% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 43 | 08-12-31 | |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Trevor McCartney
IRO | Public Communications Contact | - | 19-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 20-06-17 |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Director of Finance/CFO | 43 | 08-12-31 |
1st Jan change | Capi. | |
---|---|---|
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |